Seqens Seqens

X

Polfa Tarchomin's list of EU CTD Dossiers, Marketing Authorizations, In, Out Licensing Opportunities & Finished Dosage Formulations (FDF) aggregated by PharmaCompass

  • Webinars & Exhibitions

  • CMO of Parenteral Dosage Forms

  • R&D & Production of Highly Potent Injectables

PharmaCompass
Polfa Tarchomin VB RMU
Polfa Tarchomin
Poland Flag
Country
Country
Poland
Address
Address
A. Fleminga 2 street, 03-176 Warsaw
Telephone
Telephone
+48 225108333
Client Email
Email
Twitter
Twitter
Contact Info
Others

Powder for Oral Suspen...
600MG; 42.9MG
Poland
Dossier Availability: Q3 2024
Polfa Tarchomin VB CB

Cophex 2024

Not Confirmed

envelop Contact Supplier
Powder for solution fo...
2000MG
Poland
Polfa Tarchomin VB CB

Cophex 2024

Not Confirmed

envelop Contact Supplier
Powder for solution fo...
1000MG
Poland
Polfa Tarchomin VB CB

Cophex 2024

Not Confirmed

envelop Contact Supplier
Powder for Solution fo...
500MG
Poland
Dossier Available
Polfa Tarchomin VB CB

Cophex 2024

Not Confirmed

envelop Contact Supplier
Powder for Solution fo...
2000MG
Poland
Dossier Available
Polfa Tarchomin VB CB

Cophex 2024

Not Confirmed

envelop Contact Supplier
Powder for Solution fo...
1000MG
Poland
Dossier Available
Polfa Tarchomin VB CB

Cophex 2024

Not Confirmed

envelop Contact Supplier
Powder for Solution fo...
500MG; 250MG
Poland
Dossier Availability: Q1 2024
Polfa Tarchomin VB CB

Cophex 2024

Not Confirmed

envelop Contact Supplier
Powder for Solution fo...
2000MG; 1000MG
Poland
Dossier Availability: Q1 2024
Polfa Tarchomin VB CB

Cophex 2024

Not Confirmed

envelop Contact Supplier
Powder for Solution fo...
1000MG; 500MG
Poland
Dossier Availability: Q1 2024
Polfa Tarchomin VB CB

Cophex 2024

Not Confirmed

envelop Contact Supplier
Powder for Solution fo...
100MG
Poland
Dossier Available
Polfa Tarchomin VB CB

Cophex 2024

Not Confirmed

envelop Contact Supplier
Powder for Solution fo...
3.5MG
Poland
Dossier Available
Polfa Tarchomin VB CB

Cophex 2024

Not Confirmed

envelop Contact Supplier
Powder for Infusion So...
70MG
Poland
Dossier Availability: Q2 2024
Polfa Tarchomin VB CB

Cophex 2024

Not Confirmed

envelop Contact Supplier
Powder for Infusion So...
50MG
Poland
Dossier Availability: Q2 2024
Polfa Tarchomin VB CB

Cophex 2024

Not Confirmed

envelop Contact Supplier
Tablet
0.5MG
Poland
Dossier Available
Polfa Tarchomin VB CB

Cophex 2024

Not Confirmed

envelop Contact Supplier
Solution for Injection
1MG/ML
Poland
Dossier Available
Polfa Tarchomin VB CB

Cophex 2024

Not Confirmed

envelop Contact Supplier
Tablet
2MG
Poland
Dossier Available
Polfa Tarchomin VB CB

Cophex 2024

Not Confirmed

envelop Contact Supplier
Powder for Solution fo...
2000MG
Poland
Dossier Availability: Q4 2023
Polfa Tarchomin VB CB

Cophex 2024

Not Confirmed

envelop Contact Supplier
Powder for Solution fo...
1000MG
Poland
Dossier Available
Polfa Tarchomin VB CB

Cophex 2024

Not Confirmed

envelop Contact Supplier
Powder for Injection/I...
1000000IU
Poland
Dossier Available
Polfa Tarchomin VB CB

Cophex 2024

Not Confirmed

envelop Contact Supplier
Powder for Injection/I...
2000000IU
Poland
Dossier Available
Polfa Tarchomin VB CB

Cophex 2024

Not Confirmed

envelop Contact Supplier
Powder for Solution fo...
1000000IU
Poland
Dossier Available
Polfa Tarchomin VB CB

Cophex 2024

Not Confirmed

envelop Contact Supplier
Powder for Injection/I...
3000000IU
Poland
Dossier Available
Polfa Tarchomin VB CB

Cophex 2024

Not Confirmed

envelop Contact Supplier
Coated Tablet
5MG
Poland
Dossier Availability: Q3 2025
Polfa Tarchomin VB CB

Cophex 2024

Not Confirmed

envelop Contact Supplier
Coated Tablet
10MG
Poland
Dossier Availability: Q3 2025
Polfa Tarchomin VB CB

Cophex 2024

Not Confirmed

envelop Contact Supplier
Solution for Infusion
20MG/ML
Poland
Dossier Available
Polfa Tarchomin VB CB

Cophex 2024

Not Confirmed

envelop Contact Supplier
Coated Tablet
10MG
Poland
Dossier Availability: Q2 2027
Polfa Tarchomin VB CB

Cophex 2024

Not Confirmed

envelop Contact Supplier
Coated Tablet
25MG
Poland
Dossier Availability: Q2 2027
Polfa Tarchomin VB CB

Cophex 2024

Not Confirmed

envelop Contact Supplier
Granulate Powder for S...
3000MG
Poland
Dossier Availability: Q2 2024
Polfa Tarchomin VB CB

Cophex 2024

Not Confirmed

envelop Contact Supplier
Powder for Solution fo...
40MG/ML
Poland
Dossier Availability: Q2 2025
Polfa Tarchomin VB CB

Cophex 2024

Not Confirmed

envelop Contact Supplier
Solution for Injection
250MG/5ML
Poland
Dossier Availability: Q1 2027
Polfa Tarchomin VB CB

Cophex 2024

Not Confirmed

envelop Contact Supplier
Suspension for Cutaneo...
1.372MG/GM
Poland
Dossier Available
Polfa Tarchomin VB CB

Cophex 2024

Not Confirmed

envelop Contact Supplier
Coated Tablet
200MG
Poland
Dossier Available
Polfa Tarchomin VB CB

Cophex 2024

Not Confirmed

envelop Contact Supplier
Tablet
1MG
Poland
Dossier Available
Polfa Tarchomin VB CB

Cophex 2024

Not Confirmed

envelop Contact Supplier
Solution for Injection
2MG/ML
Poland
Dossier Available
Polfa Tarchomin VB CB

Cophex 2024

Not Confirmed

envelop Contact Supplier
Tablet
0.5MG
Poland
Dossier Available
Polfa Tarchomin VB CB

Cophex 2024

Not Confirmed

envelop Contact Supplier
Tablet
2.5MG
Poland
Dossier Available
Polfa Tarchomin VB CB

Cophex 2024

Not Confirmed

envelop Contact Supplier
Solution for Injection
4MG/ML
Poland
Dossier Available
Polfa Tarchomin VB CB

Cophex 2024

Not Confirmed

envelop Contact Supplier
Hard Capsule
300MG
Poland
Dossier Availability: Q3 2025
Polfa Tarchomin VB CB

Cophex 2024

Not Confirmed

envelop Contact Supplier
Hard Capsule
150MG
Poland
Dossier Availability: Q3 2025
Polfa Tarchomin VB CB

Cophex 2024

Not Confirmed

envelop Contact Supplier
Solution for Injection
1000MG/2ML
Poland
Dossier Availability: Q3 2024
Polfa Tarchomin VB CB

Cophex 2024

Not Confirmed

envelop Contact Supplier
Solution for Injection
2500MG/5ML
Poland
Dossier Availability: Q3 2024
Polfa Tarchomin VB CB

Cophex 2024

Not Confirmed

envelop Contact Supplier
Extended Release Table...
500MG
Poland
Dossier Availability: Q1 2025
Polfa Tarchomin VB CB

Cophex 2024

Not Confirmed

envelop Contact Supplier
Extended Release Table...
1000MG
Poland
Dossier Availability: Q1 2025
Polfa Tarchomin VB CB

Cophex 2024

Not Confirmed

envelop Contact Supplier
Extended Release Table...
750MG
Poland
Dossier Availability: Q1 2025
Polfa Tarchomin VB CB

Cophex 2024

Not Confirmed

envelop Contact Supplier
Solution for Injection
50MG/ML
Poland
Dossier Availability: Q3 2026
Polfa Tarchomin VB CB

Cophex 2024

Not Confirmed

envelop Contact Supplier
Powder for Infusion So...
100MG
Poland
Dossier Availability: Q3 2024
Polfa Tarchomin VB CB

Cophex 2024

Not Confirmed

envelop Contact Supplier
Powder for Infusion So...
50MG
Poland
Dossier Availability: Q3 2024
Polfa Tarchomin VB CB

Cophex 2024

Not Confirmed

envelop Contact Supplier
Gel
20MG/GM
Poland
Dossier Available
Polfa Tarchomin VB CB

Cophex 2024

Not Confirmed

envelop Contact Supplier
Solution for Infusion
10MG/ML
Poland
Dossier Availability: Q3 2024
Polfa Tarchomin VB CB

Cophex 2024

Not Confirmed

envelop Contact Supplier
Solution for Infusion
20MG/ML
Poland
Dossier Availability: Q3 2024
Polfa Tarchomin VB CB

Cophex 2024

Not Confirmed

envelop Contact Supplier
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY